Literature DB >> 25647752

The association of depression, cognitive impairment without dementia, and dementia with risk of ischemic stroke: a cohort study.

Dimitry S Davydow1, Deborah A Levine, Kara Zivin, Wayne J Katon, Kenneth M Langa.   

Abstract

OBJECTIVE: To determine if depression, cognitive impairment without dementia (CIND), and/or dementia are each independently associated with risk of ischemic stroke and to identify characteristics that could modify these associations.
METHODS: This retrospective-cohort study examined a population-based sample of 7031 Americans older than 50 years participating in the Health and Retirement Study (1998-2008) who consented to have their interviews linked to their Medicare claims. The eight-item Center for Epidemiologic Studies Depression Scale and/or International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) depression diagnoses were used to identify baseline depression. The Modified Telephone Interview for Cognitive Status and/or ICD-9-CM dementia diagnoses were used to identify baseline CIND or dementia. Hospitalizations for ischemic stroke were identified via ICD-9-CM diagnoses.
RESULTS: After adjusting for demographics, medical comorbidities, and health-risk behaviors, CIND alone (odds ratio [OR] = 1.37, 95% confidence interval [CI] = 1.11-1.69) and co-occurring depression and CIND (OR = 1.65, 95% CI = 1.24-2.18) were independently associated with increased odds of ischemic stroke. Depression alone was not associated with odds of ischemic stroke (OR = 1.11, 95% CI = 0.88-1.40) in unadjusted analyses. Neither dementia alone (OR = 1.09, 95% CI = 0.82-1.45) nor co-occurring depression and dementia (OR = 1.25, 95% CI = 0.89-1.76) were associated with odds of ischemic stroke after adjusting for demographics.
CONCLUSIONS: CIND and co-occurring depression and CIND are independently associated with increased risk of ischemic stroke. Individuals with co-occurring depression and CIND represent a high-risk group that may benefit from targeted interventions to prevent stroke.

Entities:  

Mesh:

Year:  2015        PMID: 25647752      PMCID: PMC4333011          DOI: 10.1097/PSY.0000000000000136

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  43 in total

1.  Recent trends in cost-related medication nonadherence among stroke survivors in the United States.

Authors:  Deborah A Levine; Lewis B Morgenstern; Kenneth M Langa; John D Piette; Mary A M Rogers; Sudeep J Karve
Journal:  Ann Neurol       Date:  2013-02-22       Impact factor: 10.422

2.  Cognitive impairment as a strong predictor of incident disability in specific ADL-IADL tasks among community-dwelling elders: the Azuchi Study.

Authors:  Hiroko H Dodge; Takashi Kadowaki; Takehito Hayakawa; Masanobu Yamakawa; Akira Sekikawa; Hirotugu Ueshima
Journal:  Gerontologist       Date:  2005-04

3.  Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000.

Authors:  Kurt J Greenlund; Janet B Croft; George A Mensah
Journal:  Arch Intern Med       Date:  2004-10-25

4.  Incidence of stroke in people with Alzheimer disease: a national register-based approach.

Authors:  Anna-Maija Tolppanen; Piia Lavikainen; Alina Solomon; Miia Kivipelto; Hilkka Soininen; Sirpa Hartikainen
Journal:  Neurology       Date:  2013-01-02       Impact factor: 9.910

5.  Depressive symptoms, inflammation, and ischemic stroke in older adults: a prospective analysis in the cardiovascular health study.

Authors:  Jose J Arbelaez; Abraham A Ariyo; Rosa M Crum; Linda P Fried; Daniel E Ford
Journal:  J Am Geriatr Soc       Date:  2007-10-03       Impact factor: 5.562

6.  The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression.

Authors:  Wayne J Katon; Michael Von Korff; Elizabeth H B Lin; Greg Simon; Evette Ludman; Joan Russo; Paul Ciechanowski; Edward Walker; Terry Bush
Journal:  Arch Gen Psychiatry       Date:  2004-10

7.  Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data.

Authors:  Christianne L Roumie; Edward Mitchel; Patricia S Gideon; Cristina Varas-Lorenzo; Jordi Castellsague; Marie R Griffin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-01       Impact factor: 2.890

8.  Alzheimer disease and risk of stroke: a population-based cohort study.

Authors:  Nai-Fang Chi; Li-Nien Chien; Hsiao-Lun Ku; Chaur-Jong Hu; Hung-Yi Chiou
Journal:  Neurology       Date:  2013-01-09       Impact factor: 9.910

Review 9.  Psychological treatments for depression and anxiety in dementia and mild cognitive impairment.

Authors:  Vasiliki Orgeta; Afifa Qazi; Aimee E Spector; Martin Orrell
Journal:  Cochrane Database Syst Rev       Date:  2014-01-22

10.  Low socioeconomic status and psychological distress as synergistic predictors of mortality from stroke and coronary heart disease.

Authors:  Antonio Ivan Lazzarino; Mark Hamer; Emmanuel Stamatakis; Andrew Steptoe
Journal:  Psychosom Med       Date:  2013-03-26       Impact factor: 4.312

View more
  12 in total

1.  Personality traits and risk of cognitive impairment and dementia.

Authors:  Antonio Terracciano; Yannick Stephan; Martina Luchetti; Emiliano Albanese; Angelina R Sutin
Journal:  J Psychiatr Res       Date:  2017-01-22       Impact factor: 4.791

2.  Cognitive Impairment, Dementia, and Personality Stability Among Older Adults.

Authors:  Antonio Terracciano; Yannick Stephan; Martina Luchetti; Angelina R Sutin
Journal:  Assessment       Date:  2017-02-01

3.  Prevalence of Combined Somatic and Mental Health Multimorbidity: Patterns by Age, Sex, and Race/Ethnicity.

Authors:  William V Bobo; Barbara P Yawn; Jennifer L St Sauver; Brandon R Grossardt; Cynthia M Boyd; Walter A Rocca
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-03-02       Impact factor: 6.053

Review 4.  Risk of hemorrhagic and ischemic stroke in patients with Alzheimer disease: A synthesis of the literature.

Authors:  Reem Waziry; Lori B Chibnik; Daniel Bos; M Kamran Ikram; Albert Hofman
Journal:  Neurology       Date:  2020-01-16       Impact factor: 9.910

5.  Using Medicare claims in identifying Alzheimer's disease and related dementias.

Authors:  Siddharth Jain; Paul R Rosenbaum; Joseph G Reiter; Geoffrey Hoffman; Dylan S Small; Jinkyung Ha; Alexander S Hill; David A Wolk; Timothy Gaulton; Mark D Neuman; Roderic G Eckenhoff; Lee A Fleisher; Jeffrey H Silber
Journal:  Alzheimers Dement       Date:  2020-10-08       Impact factor: 21.566

Review 6.  Vascular-brain Injury Progression after Stroke (VIPS) study: concept for understanding racial and geographic determinants of cognitive decline after stroke.

Authors:  Fred Stephen Sarfo; Rufus Akinyemi; George Howard; Virginia J Howard; Kolawole Wahab; Mary Cushman; Deborah A Levine; Adesola Ogunniyi; Fred Unverzagt; Mayowa Owolabi; Bruce Ovbiagele
Journal:  J Neurol Sci       Date:  2020-02-19       Impact factor: 4.553

7.  Health Self-Efficacy Among Populations with Multiple Chronic Conditions: the Value of Patient-Centered Communication.

Authors:  Lila J Finney Rutten; Bradford W Hesse; Jennifer L St Sauver; Patrick Wilson; Neetu Chawla; Danielle B Hartigan; Richard P Moser; Stephen Taplin; Russell Glasgow; Neeraj K Arora
Journal:  Adv Ther       Date:  2016-06-29       Impact factor: 3.845

8.  Potential Value of Impaired Cognition in Stroke Prediction: A U.K. Population-Based Study.

Authors:  Blossom C M Stephan; Kathryn Richardson; George M Savva; Fiona E Matthews; Carol Brayne; Vladimir Hachinski
Journal:  J Am Geriatr Soc       Date:  2017-04-03       Impact factor: 5.562

9.  Social disparities in the prevalence of multimorbidity - A register-based population study.

Authors:  Michaela L Schiøtz; Anders Stockmarr; Dorte Høst; Charlotte Glümer; Anne Frølich
Journal:  BMC Public Health       Date:  2017-05-10       Impact factor: 3.295

10.  Feeling Older and the Development of Cognitive Impairment and Dementia.

Authors:  Yannick Stephan; Angelina R Sutin; Martina Luchetti; Antonio Terracciano
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2017-10-01       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.